Catalent, facing pressure from Elliott, had other activists in stock
By Svea Herbst-Bayliss NEW YORK (Reuters) – Contract drugmaker Catalent,
By Svea Herbst-Bayliss NEW YORK (Reuters) – Contract drugmaker Catalent,
By Maggie Fick LONDON (Reuters) – Activist investor Elliott Investment